Raymon Heather 4
4 · Artiva Biotherapeutics, Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Raymon Heather
SVP, Research and Development
Transactions
- Award
Common Stock
2025-02-26+33,350→ 43,350 total
Footnotes (1)
- [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.